What Is CJC-1295 No DAC Used For?

CJC-1295 no DAC is a synthetic growth hormone-releasing hormone (GHRH) analog used in research to trigger growth hormone (GH) release from the pituitary gland. Labs typically study it for short, natural-like GH pulses, most often stacked with a ghrelin-receptor agonist such as ipamorelin. It is not FDA-approved for human use and is legally sold only as a research chemical.

What "No DAC" Actually Means

The "DAC" in CJC-1295 stands for Drug Affinity Complex, a maleimide linker that lets the peptide bind to albumin in the blood. CJC-1295 with DAC carries that linker; CJC-1295 no DAC does not.

Because nothing holds it in circulation, CJC-1295 no DAC clears in about 30 minutes. The DAC version stays active for roughly 6 to 8 days. That difference in duration is the main practical reason researchers pick one over the other. Searching what is cjc-1295 without dac usually leads to this same explanation.

What Is CJC-1295 No DAC Used For in Research?

Its primary research use is stimulating pituitary GH release. The peptide binds GHRH receptors on somatotroph cells and triggers a burst of growth hormone, which is why it is classified as a GH secretagogue rather than a hormone itself.

Common research focuses include:

• Pulsatile GH secretion — how the pituitary responds to a single, short GHRH signal.
• Stacked secretagogue studies — pairing a GHRH analog with a ghrelin mimetic to measure additive GH release.
• Downstream markers — tracking IGF-1, glucose, and body-composition changes in animal models.
• Pharmacokinetics — comparing delivery routes and half-life curves.

People often ask what does cjc 1295 no dac do compared with the long-acting form. The short answer is that it produces sharper, shorter GH pulses instead of a sustained elevation.

CJC-1295 With DAC vs Without DAC

Feature	CJC-1295 No DAC	CJC-1295 With DAC
Also called	Mod GRF 1-29	CJC-1295 DAC
Half-life	About 30 minutes	About 6 to 8 days
Albumin binding	None	Yes, through the DAC linker
GH pattern	Pulsatile, closer to natural rhythm	Sustained elevation
Typical research timing	Multiple small doses per day	Infrequent, spread-out dosing
Main research interest	Pulsatility and stacking	Long exposure and IGF-1 response

The question of cjc-1295 dac vs no dac which is better has no single answer. Short pulses and long elevation answer different research questions, and the right choice depends entirely on the study design.

How It Fits Into Common Peptide Stacks

Many people first ask what is cjc-1295 ipamorelin used for before they look into either compound separately. The pairing gets attention in research because the two act on different receptors, GHRH and ghrelin, which can produce a larger GH response together than either does alone.

Research Peptide	Receptor Target	Studied Rationale
CJC-1295 no DAC	GHRH receptor	Baseline growth hormone pulse
Ipamorelin	Ghrelin receptor	Selective GH release with less cortisol and prolactin impact
GHRP-2	Ghrelin receptor	Stronger GH and appetite signaling
GHRP-6	Ghrelin receptor	GH release plus hunger and gastric effects

How Research Protocols Usually Approach Timing

Because CJC-1295 no DAC clears quickly, research protocols tend to use frequent, small administrations rather than one large weekly injection. Timing is usually built around natural GH peaks, which occur during deep sleep and after fasting.

Protocols in the literature vary widely, and no standard human dose exists that anyone should copy from a forum or vendor page. Published studies run under controlled conditions with monitoring, which is not the same as self-administering an unapproved peptide.

Safety, Legal Status, and Buyer Awareness

CJC-1295 no DAC is not FDA-approved for human use in the United States. Products sold as research chemicals are intended for laboratory work, and a research label does not make them safe or legal for personal use.

Reported effects from related GHRH analogs in human trials include injection-site irritation, flushing, headache, and shifts in blood sugar or IGF-1. Long-term data in healthy people is limited.

Anyone weighing peptide use should speak with a licensed healthcare professional first. If you come across cjc 1295 no dac for sale online, check the vendor's third-party testing reports, purity documentation, and shipping disclosures before assuming the product matches the label.

Key Takeaways

• CJC-1295 no DAC is a short-acting GHRH analog studied for pulsatile growth hormone release.
• Its half-life is roughly 30 minutes, compared with 6 to 8 days for CJC-1295 with DAC.
• It is most often studied alongside ipamorelin and other ghrelin-receptor agonists.
• CJC-1295 no DAC is not FDA-approved for human use and is sold for research purposes only.
• Dosing decisions belong with a qualified healthcare professional, not a vendor page.

COMMON QUESTIONS

Frequently Asked Questions

Is CJC-1295 no DAC approved for human use in the US?

No. CJC-1295 no DAC is not FDA-approved for human use in the United States and is sold strictly as a research chemical. It has not completed the safety and efficacy trials required for a prescription drug. Any product marketed for human consumption sits in a legal gray area.

How long does CJC-1295 no DAC stay active in the body?

CJC-1295 no DAC has a half-life of roughly 30 minutes, so it clears quickly compared with the DAC version. CJC-1295 with DAC lasts about 6 to 8 days because its linker binds the peptide to albumin. The shorter duration is why research protocols using the no-DAC form tend to involve more frequent, smaller administrations.

What is CJC-1295 no DAC commonly stacked with in research?

It is most often paired with ipamorelin, a ghrelin-receptor agonist that works through a different pathway. Researchers study that combination for additive growth hormone release. Other pairings in the literature include GHRP-2 and GHRP-6, though those are linked to stronger appetite and cortisol effects.